Biomarkers

A fragment of the C-terminal domain of type XII collagen, enabling non-invasive monitoring of cancer-associated fibroblast (CAFs) activity and extracellular matrix remodeling in solid tumors.

A fragment of the C-terminal domain of type XVI FACIT collagen, enabling non-invasive monitoring of extracellular matrix remodeling and fibrostenotic activity in gastrointestinal disorders such as colorectal cancer and Crohn's disease.

A fragment of the ectodomain of type XVII collagen, enabling non-invasive monitoring of epithelial damage and basement membrane remodeling in skin and gastrointestinal disorders.

A fragment of the C-terminal domain of type XIX collagen, enabling non-invasive monitoring of basement membrane remodeling and extracellular matrix dynamics in oncology research.

A fragment of the C-terminal domain of type XX collagen, enabling non-invasive monitoring of extracellular matrix remodeling and tumor-associated fibrosis across multiple solid tumor types.

C-terminal of type XXII collagen. FACIT collagen measuring tissue formation, molecular bridging and tissue organization. A fragment of the C-terminal domain of type XXII FACIT collagen, enabling non-invasive monitoring of extracellular matrix organization, molecular bridging and tumor-associated fibrosis across multiple solid tumor types.

A fragment of the 7S domain of type IV collagen, enabling non-invasive monitoring of basement membrane formation and epithelial extracellular matrix remodeling in fibrotic and inflammatory diseases.

A fragment of the C-terminal propeptide of type V fibrillar collagen, enabling non-invasive monitoring of extracellular matrix, myfibroblast and cancer-associated fibroblast (CAFs) formation, indicating fibrotic activity in hepatic and oncological conditions.

A fragment of the C-terminal domain of type VII collagen, the only anchoring fibril, enabling non-invasive monitoring of dermal-epidermal junction integrity and extracellular matrix formation in skin and intestinal tissue remodeling.

A fragment of the NC1 domain of type VIII collagen, enabling non-invasive monitoring of epithelial basement membrane remodeling and tumor-associated fibrosis in solid tumors.